Breadcrumb
- Home
- Publications
- Proceedings
- 2012 AIChE Annual Meeting
- Biomedical Applications of Chemical Engineering
- Engineering Stem Cell Therapy II
- (558f) Cytosolic Delivery of Reprogramming Factors with a Microfluidic Device
By use of our microfluidic device, cells are forced through a constriction which creates pores on the membrane of the cell. This approach has many benefits, one of which is that our method is not material specific. Cells are suspended in solution with the protein of interest to deliver the protein. The second benefit of this method is the robustness to cell type. This microfluidic device works with established cell lines, immune cells, stem cells, as well as skin cells.
While this device is applicable to more than just protein delivery, this specific project focuses on the delivery of reprogramming factors, which are proteins, to skin cells to induce reprogramming into a pluripotent state. These induced pluripotent stem cells (iPS cells) have many benefits such as patient-specific tissues and the creation of immortalized model cell lines for diseases such as Parkinson’s. The benefits of a fast and efficient method of creating iPS cells do not just extend to research, but also to potential clinical and tissue engineering applications as well.